CNO Financial Group, Inc. filed a Form 8-K on September 1, 2026, disclosing that it issued an investor briefing presentation focused on its Worksite Division and Medicare business.

Key Highlights

  • Briefing subject: The presentation covers CNO Financial Group's Worksite Division and Medicare business.
  • Date of event: The presentation was issued on September 1, 2026.
  • Regulation FD: The disclosure was made under Item 7.01, Regulation FD Disclosure.
  • Availability: The presentation and future updates will be posted in the Investors section of the company's website at ir.CNOinc.com.
  • Filing status: The information is furnished, not filed, and is "not deemed 'filed' for purposes of Section 18 of the Securities and Exchange Act of 1934," according to the filing.
  • Signatory: The report was signed by Joel T. Koehneman, Senior Vice President and Chief Accounting Officer.

CNO Financial Group Discloses Worksite and Medicare Investor Presentation Under Regulation FD

CNO Financial Group, Inc. (NYSE:CNO), a Delaware-incorporated insurance holding company headquartered at 11299 Illinois Street, Carmel, Indiana 46032, submitted a Current Report on Form 8-K dated September 1, 2026. The filing was made pursuant to Item 7.01, Regulation FD Disclosure, and relates to a presentation the company issued for an upcoming investor briefing focused on its Worksite Division and Medicare business.

According to the filing, the presentation is attached as Exhibit 99.1, titled "Worksite Division and Medicare business Investor Briefing - September 2026." The company disclosed that this presentation, along with any future updates, will be made available in the Investors section of its website at ir.CNOinc.com. The filing does not include the underlying financial data or operational metrics contained in the presentation itself, as the exhibit text was not reproduced in the filing excerpt provided.

The company stated that the information furnished in the Current Report, including Exhibit 99.1, "shall not be deemed 'filed' for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended," and is therefore not subject to the liabilities of that section. The filing further specified that the information shall not be incorporated by reference into any registration statement or other document unless expressly set forth by specific reference. The report was signed by Joel T. Koehneman, Senior Vice President and Chief Accounting Officer, on September 1, 2026.

What Was Disclosed

CNO Financial Group filed a Form 8-K on September 1, 2026, under Regulation FD, furnishing an investor briefing presentation on its Worksite Division and Medicare business as Exhibit 99.1, available on the company's investor relations website.